Apparatus and method for an ultrasonic probe used with a pharmacological agent
First Claim
1. An ultrasonic medical device comprising:
- an ultrasonic probe having a proximal end, a distal end and a longitudinal axis therebetween; and
a catheter surrounding a length of the longitudinal axis of the ultrasonic probe, wherein the catheter delivers a pharmacological agent to treat an occlusion and enhance an occlusion treating effect of the ultrasonic probe to ablate the occlusion.
4 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides an apparatus and a method of using an ultrasonic probe with a pharmacological agent to enhance an occlusion treating effect of the ultrasonic probe to effectively remove an occlusion. The pharmacological agent is released through a catheter to treat the occlusion and enhance an effect of a transverse ultrasonic vibration of the ultrasonic probe to effectively remove the occlusion. The pharmacological agent continues to travel downstream of the site of the occlusion and work in conjunction with the ultrasonic probe to reduce the occlusion to a size that can easily be removed from the body naturally in order to prevent reformation of the occlusion and other health risks.
-
Citations
68 Claims
-
1. An ultrasonic medical device comprising:
-
an ultrasonic probe having a proximal end, a distal end and a longitudinal axis therebetween; and
a catheter surrounding a length of the longitudinal axis of the ultrasonic probe, wherein the catheter delivers a pharmacological agent to treat an occlusion and enhance an occlusion treating effect of the ultrasonic probe to ablate the occlusion. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)
-
-
20. An ultrasonic medical device for ablating an occlusion comprising:
-
an elongated, flexible probe having a proximal end, a distal end and a longitudinal axis therebetween; and
a catheter surrounding a length of the longitudinal axis of the elongated, flexible probe, wherein a pharmacological agent moves through the catheter to enhance an effect of a transverse ultrasonic vibration of the elongated, flexible probe to ablate the occlusion. - View Dependent Claims (21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)
-
-
38. A method of treating an occlusion comprising:
-
inserting an ultrasonic probe in a vasculature of a body;
delivering a catheter over a length of a longitudinal axis of the ultrasonic probe;
releasing a pharmacological agent through the catheter;
exposing a section of the longitudinal axis of the ultrasonic probe to the occlusion; and
activating an ultrasonic source to provide an ultrasonic energy to the ultrasonic probe wherein the pharmacological agent enhances an occlusion treating effect of the ultrasonic probe by working in combination with the ultrasonic probe at a site of the occlusion and downstream of the site of the occlusion. - View Dependent Claims (39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60)
-
-
61. A method of removing an occlusion comprising:
-
moving an elongated, flexible probe through a vasculature to a site of the occlusion;
releasing a pharmacological agent in the vasculature having the occlusion to enhance an occlusion removing effect of the elongated, flexible probe; and
activating an ultrasonic energy source to vibrate a longitudinal axis of the elongated, flexible probe in a transverse direction to remove the occlusion. - View Dependent Claims (62, 63, 64, 65, 66, 67, 68)
-
Specification